FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

Did You Know?
FDA/DIA Workshop: Defining and implementing quality in clinical investigations -- from design to completion

FDA's Office of Critical Path Programs and DIA are co-sponsoring a first-of-its-kind workshop on "Defining and implementing quality in clinical investigations: from design to completion." The focus of the workshop is building quality into the clinical investigations—from inception through completion. As clinical investigations become more complex and global, FDA must continue to evolve and modernize the oversight and monitoring of research. Join us from May 10 to 11, 2007, at the Marriott Hotel, Washington, DC.

The workshop is part of the FDA's BIMO (Bioresearch Monitoring) Initiative, announced June 2006, which is specifically concerned with protecting human subjects and ensuring the integrity of data in clinical trials. This workshop is part of that long-term effort. Topics of discussion at the workshop will include:

• Defining Quality
• Implementing Quality
• Design and Measurement
• Implementing Quality: Integrity
• Summary and Path Forward

Registration is now available.

Critical Path Home Page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff